Trials / Completed
CompletedNCT02673047
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 474 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will describe the prescription conditions of botulinum toxin Type A (Botox®) injection for the treatment of urinary incontinence due to neurogenic detrusor overactivity (NDO) or idiopathic overactive bladder (IOAB) as per standard of care in clinical practice in France.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A (Botox®) injection as prescribed as standard of care in clinical practice. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-02-03
- Last updated
- 2016-10-24
Locations
50 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02673047. Inclusion in this directory is not an endorsement.